Jury Nullifies Novartis’ Patent on Corn Seed
- Share via
Novartis, the world’s largest agricultural products company, lost a bid to collect $194 million from Monsanto Co. and DeKalb Genetics Corp. when a jury invalidated the Swiss company’s corn seed patent Monday.
After a two-week trial, a federal jury in Wilmington, Del., also said Novartis failed to prove that Monsanto or DeKalb infringed patent claims. The patent, filed in 1987, was awarded last year.
The verdict was a significant victory for St. Louis-based Monsanto and DeKalb, Ill.-based DeKalb, which claimed that their scientists invented the technology for inserting a particular gene into corn plants to produce a protein that kills corn-eating insects. The market for such bioengineered crops could reach $20 billion in the next decade, analysts say.
Novartis said it plans to appeal.
It’s now questionable whether either Monsanto or Novartis has an exclusive legal claim on the pest-resistant corn since juries have invalidated patents of both companies.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
